Takeshi Iwatsubo, MD

Affiliations: 
Neuropathology and Neuroscience The University of Tokyo 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=45
Website:
http://www.sss.jst.go.jp/english/researcher/h19-02iwatsubo.html
Google:
"Takeshi Iwatsubo"
Bio:

http://www.alzforum.org/com/res/detail.asp?id={FB389991-D859-4E72-8CBA-111EEDEE7152}

http://www.alz.org/ICAD/icad_award_winners.asp

Mean distance: 18.85 (cluster 31)
 
SNBCP
Cross-listing: Alzheimer's Tree - Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hampel H, Hardy J, Blennow K, et al. (2021) The Amyloid-β Pathway in Alzheimer's Disease. Molecular Psychiatry
Sato K, Niimi Y, Ihara R, et al. (2021) Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study. Journal of Medical Internet Research. 23: e26284
Sato K, Mano T, Niimi Y, et al. (2021) The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database. Bioscience Trends
Samara M, Levine SZ, Yoshida K, et al. (2021) Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of Donepezil. Journal of Alzheimer's Disease : Jad
Hampel H, Shaw LM, Aisen P, et al. (2021) State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sato K, Ihara R, Suzuki K, et al. (2021) Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study. Alzheimer's & Dementia (New York, N. Y.). 7: e12135
Levine SZ, Goldberg Y, Yoshida K, et al. (2021) Quantifying the Heterogeneity of Cognitive Functioning in Alzheimer's Disease to extend the Placebo-Treatment Dichotomy: Latent class analysis of Individual-Participant Data from Five Pivotal Randomized Clinical Trials of Donepezil. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-26
Matsukawa K, Kukharsky MS, Park SK, et al. (2021) Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy. Rna Biology. 1-9
Hashimoto T, Fujii D, Naka Y, et al. (2020) Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques. Acta Neuropathologica Communications. 8: 212
Levine SZ, Yoshida K, Goldberg Y, et al. (2020) Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil. Evidence-Based Mental Health
See more...